Croda International Plc, creator, manufacturer and supplier of high-performance ingredients and technologies for some of the world's leading brands, announced on January 11 the acquisition of Nautilus Biosciences Canada Inc ('Nautilus'), a marine biotechnology company based in Charlottetown, Prince Edward Island, Canada.
Nautilus was founded in 2007 by Professor Russell Kerr, who, together with a team of internationally renowned scientists, focuses on using marine microbial biodiversity to discover new materials and active ingredients. Thanks to this acquisition and the associated patents, Croda will be applying this innovative science to all its business sectors.
Croda and Nautilus have successfully collaborated in the past, having worked closely together for the past six years, developing specific applications for skin and hair care as well as plant protection.
Steve Foots, CEO of Croda , commented: "This is yet another clear example of how sustainable innovation fits into our growth plans. With Nautilus now part of the Croda Group, we are further extending our expertise in biotechnology. The Nautilus team, which will be joining us, has a wealth of knowledge and expertise in marine biotechnology, also known as "blue biotechnology". We will be able to bring new patented products to market to complement our renowned ingredients in green and white biotechnology, giving us a broad spectrum of possibilities in this area of science".
Professor Russell Kerr, founder of Nautilus , added: "We have enjoyed a collaborative and positive relationship with Croda and the University of Prince Edward Island for many years, and have been impressed by Croda's commitment to developing marine biotechnology opportunities. Becoming part of the Croda group will provide Nautilus with the resources and support to establish a key center for the research and development of natural products derived from the marine world, and will provide Croda with new commercial successes".
